CY1117814T1 - Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου - Google Patents
Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμουInfo
- Publication number
- CY1117814T1 CY1117814T1 CY20161100677T CY161100677T CY1117814T1 CY 1117814 T1 CY1117814 T1 CY 1117814T1 CY 20161100677 T CY20161100677 T CY 20161100677T CY 161100677 T CY161100677 T CY 161100677T CY 1117814 T1 CY1117814 T1 CY 1117814T1
- Authority
- CY
- Cyprus
- Prior art keywords
- local
- nerval
- exclusion
- local anesthesia
- medicament
- Prior art date
Links
- 238000002690 local anesthesia Methods 0.000 title abstract 3
- 230000007717 exclusion Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 102000008186 Collagen Human genes 0.000 abstract 2
- 108010035532 Collagen Proteins 0.000 abstract 2
- 230000036592 analgesia Effects 0.000 abstract 2
- 229940035674 anesthetics Drugs 0.000 abstract 2
- 229920001436 collagen Polymers 0.000 abstract 2
- 239000003193 general anesthetic agent Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 210000005036 nerve Anatomy 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229940088679 drug related substance Drugs 0.000 abstract 1
- XPXMKIXDFWLRAA-UHFFFAOYSA-N hydrazinide Chemical compound [NH-]N XPXMKIXDFWLRAA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/692,337 US20080241243A1 (en) | 2007-03-28 | 2007-03-28 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
| IE2007/0220A IE85880B1 (en) | 2007-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
| PCT/IE2008/000035 WO2008117268A2 (en) | 2007-03-28 | 2008-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117814T1 true CY1117814T1 (el) | 2017-05-17 |
Family
ID=39540798
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100677T CY1117814T1 (el) | 2007-03-28 | 2016-07-14 | Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου |
| CY20191100409T CY1121568T1 (el) | 2007-03-28 | 2019-04-12 | Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100409T CY1121568T1 (el) | 2007-03-28 | 2019-04-12 | Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP3085363B1 (https=) |
| JP (1) | JP5372905B2 (https=) |
| CY (2) | CY1117814T1 (https=) |
| DE (1) | DE202008018583U1 (https=) |
| DK (2) | DK3085363T3 (https=) |
| ES (2) | ES2718542T3 (https=) |
| HR (2) | HRP20160743T1 (https=) |
| HU (2) | HUE043185T2 (https=) |
| IE (1) | IES20080229A2 (https=) |
| LT (1) | LT3085363T (https=) |
| PL (2) | PL2139457T3 (https=) |
| PT (2) | PT3085363T (https=) |
| SI (2) | SI2139457T1 (https=) |
| TR (1) | TR201905174T4 (https=) |
| WO (1) | WO2008117268A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE47826E1 (en) | 2007-03-28 | 2020-01-28 | Innocoll Pharmaceuticals Limited | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
| WO2010052694A2 (en) * | 2008-11-06 | 2010-05-14 | Innocoll Technologies Limited | Drug delivery implants and processes for their preparation |
| US20100278895A1 (en) | 2009-04-30 | 2010-11-04 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
| US8911427B2 (en) | 2010-12-28 | 2014-12-16 | Medtronic, Inc. | Therapeutic agent reservoir delivery system |
| AU2012347926B2 (en) * | 2011-12-05 | 2018-03-15 | Incept, Llc | Medical organogel processes and compositions |
| RS56564B1 (sr) | 2012-01-09 | 2018-02-28 | Innocoll Pharm Ltd | Modifikovan kolagen |
| JP6363115B2 (ja) * | 2013-02-28 | 2018-07-25 | ミラ ファーマ コーポレイション | 注射可能局所麻酔半固体製剤およびその組成物 |
| US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
| RU2561301C1 (ru) * | 2014-10-06 | 2015-08-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный аграрный университет имени П.А. Столыпина" | Способ трансфеморальной блокады нервов мочевого пузыря у мелких животных |
| US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
| US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
| AU2022213016A1 (en) * | 2021-02-01 | 2023-08-24 | Massey University | Post-operative pain management |
| WO2022219179A1 (en) * | 2021-04-15 | 2022-10-20 | Innocoll Pharmaceuticals Limited | Drug-release implant for soft tissue surgery |
| EP4376806A2 (en) * | 2021-07-28 | 2024-06-05 | Innocoll Pharmaceuticals Limited | Bupivacaine-collagen drug delivery implant and methods of making and using thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4125400C2 (de) * | 1991-07-31 | 2000-08-17 | Edwin Klaus | Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen |
| JPH08143449A (ja) * | 1994-11-17 | 1996-06-04 | Lederle Japan Ltd | 徐放性局所麻酔用注射剤 |
| US7119062B1 (en) * | 2001-02-23 | 2006-10-10 | Neucoll, Inc. | Methods and compositions for improved articular surgery using collagen |
| US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
| SI2415484T1 (sl) * | 2004-09-17 | 2014-10-30 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
| US20110097402A1 (en) * | 2004-09-30 | 2011-04-28 | Covalon Technologies Inc. | Non-adhesive elastic gelatin matrices |
-
2008
- 2008-03-28 EP EP16154811.0A patent/EP3085363B1/en active Active
- 2008-03-28 PL PL08719893.3T patent/PL2139457T3/pl unknown
- 2008-03-28 DK DK16154811.0T patent/DK3085363T3/en active
- 2008-03-28 DE DE202008018583.1U patent/DE202008018583U1/de not_active Expired - Lifetime
- 2008-03-28 PT PT16154811T patent/PT3085363T/pt unknown
- 2008-03-28 PT PT87198933T patent/PT2139457T/pt unknown
- 2008-03-28 ES ES16154811T patent/ES2718542T3/es active Active
- 2008-03-28 SI SI200831641A patent/SI2139457T1/sl unknown
- 2008-03-28 HR HRP20160743TT patent/HRP20160743T1/hr unknown
- 2008-03-28 TR TR2019/05174T patent/TR201905174T4/tr unknown
- 2008-03-28 IE IE20080229A patent/IES20080229A2/en not_active IP Right Cessation
- 2008-03-28 JP JP2010500426A patent/JP5372905B2/ja not_active Expired - Fee Related
- 2008-03-28 HU HUE16154811A patent/HUE043185T2/hu unknown
- 2008-03-28 EP EP08719893.3A patent/EP2139457B1/en active Active
- 2008-03-28 PL PL16154811T patent/PL3085363T3/pl unknown
- 2008-03-28 SI SI200832058T patent/SI3085363T1/sl unknown
- 2008-03-28 ES ES08719893.3T patent/ES2582368T3/es active Active
- 2008-03-28 WO PCT/IE2008/000035 patent/WO2008117268A2/en not_active Ceased
- 2008-03-28 DK DK08719893.3T patent/DK2139457T3/en active
- 2008-03-28 LT LTEP16154811.0T patent/LT3085363T/lt unknown
- 2008-03-28 HU HUE08719893A patent/HUE027803T2/en unknown
-
2016
- 2016-07-14 CY CY20161100677T patent/CY1117814T1/el unknown
-
2019
- 2019-04-12 CY CY20191100409T patent/CY1121568T1/el unknown
- 2019-04-15 HR HRP20190699TT patent/HRP20190699T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2582368T3 (es) | 2016-09-12 |
| HRP20190699T1 (hr) | 2019-07-12 |
| PL2139457T3 (pl) | 2016-11-30 |
| HUE027803T2 (en) | 2016-10-28 |
| HRP20160743T1 (hr) | 2016-09-23 |
| IES20080229A2 (en) | 2008-12-24 |
| SI3085363T1 (sl) | 2019-07-31 |
| TR201905174T4 (tr) | 2019-05-21 |
| EP2139457A2 (en) | 2010-01-06 |
| LT3085363T (lt) | 2019-06-25 |
| JP2010522738A (ja) | 2010-07-08 |
| WO2008117268A3 (en) | 2009-03-26 |
| HUE043185T2 (hu) | 2019-08-28 |
| EP2139457B1 (en) | 2016-05-04 |
| PT2139457T (pt) | 2016-07-26 |
| CY1121568T1 (el) | 2020-05-29 |
| EP3085363A1 (en) | 2016-10-26 |
| WO2008117268A2 (en) | 2008-10-02 |
| DE202008018583U1 (de) | 2016-03-14 |
| PT3085363T (pt) | 2019-05-16 |
| ES2718542T3 (es) | 2019-07-02 |
| PL3085363T3 (pl) | 2019-08-30 |
| DK3085363T3 (en) | 2019-04-29 |
| DK2139457T3 (en) | 2016-07-25 |
| JP5372905B2 (ja) | 2013-12-18 |
| EP3085363B1 (en) | 2019-03-20 |
| SI2139457T1 (sl) | 2016-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1117814T1 (el) | Διαταξη παροχης φαρμακου για την παροχη τοπικης αναλγησιας, τοπικης αναισθησιας ή νευρικου αποκλεισμου | |
| Viscusi et al. | HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study | |
| Candido et al. | Buprenorphine enhances and prolongs the postoperative analgesic effect of bupivacaine in patients receiving infragluteal sciatic nerve block | |
| Karthikeyan et al. | Randomized controlled trial on the efficacy of bilateral superficial cervical plexus block in thyroidectomy | |
| CY1117770T1 (el) | Διαδερμικο θεραπευτικο συστημα για χορηγηση της δραστικης ουσιας βουπρενορφινη | |
| Farouk | Pre-incisional epidural magnesium provides pre-emptive and preventive analgesia in patients undergoing abdominal hysterectomy | |
| CY1113575T1 (el) | Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα | |
| CY1110495T1 (el) | Χρηση ενος αγωνιστη υποδοχεα nmda για τη θεραπεια εμβοης που προκαλειται απο κοχλιακη διεγερτοτοξικοτητα | |
| BR112023000270A2 (pt) | Composto, composição farmacêutica, e, peptídeo | |
| Christou et al. | Transdermal fentanyl and its use in ovine surgery | |
| BR112013010829B8 (pt) | Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| CY1119597T1 (el) | Συνθεσεις και μεθοδοι για υπερκεραση αντοχης σε τραμαδολη | |
| Freise et al. | Single‐dose pharmacokinetics and bioavailability of a novel extended duration transdermal buprenorphine solution in cats | |
| Cicirelli et al. | Fentanyl patch versus tramadol for the control of postoperative pain in canine ovariectomy and mastectomy | |
| Sort et al. | AnAnkle Trial study protocol: a randomised trial comparing pain profiles after peripheral nerve block or spinal anaesthesia for ankle fracture surgery | |
| Kolosov et al. | Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain | |
| Evangelista et al. | Sciatic and femoral nerve blockade using bupivacaine alone, or in combination with dexmedetomidine or buprenorphine in cats | |
| Gasbjerg et al. | DEX‐2‐TKA—DEXamethasone twice for pain treatment after Total knee arthroplasty: a protocol for a randomized, blinded, three‐group multicentre clinical trial | |
| Bagdas et al. | (E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by α7 nicotinic acetylcholine receptor potentiation | |
| Jendi et al. | Comparison of local anaesthetic efficacy of tramadol versus lignocaine for extraction of tooth under supraperiosteal infiltration | |
| Rodriguez-Navarro et al. | Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: development of a long-acting pain blocker | |
| Bahrenberg et al. | Antinociceptive effects of epidural magnesium sulphate alone and in combination with morphine in dogs | |
| Pezzanite et al. | Liposomal bupivacaine is both safe and effective when administered via local infiltration at surgical site and mesovarium for laparoscopic ovariectomy in mares | |
| WO2008138089A3 (en) | Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer | |
| Özgen et al. | Short-and long-term results of clinical effectiveness of sodium hyaluronate injection in supraspinatus tendinitis |